Use of Galactomannan Enzyme Immunoassay for Diagnosis of Invasive Aspergillosis in a Tertiary-Care Center over a 12-Month Period

Invasive pulmonary disease caused by Aspergillus species is an increasing concern for patients who are immunosuppressed, especially patients with neutropenia or hematologic malignancies ([6][1]). Since invasive aspergillosis can be difficult to diagnose, tests have been developed to combat this